L-asparaginase (ASPG) is used to treat acute lymphoblastic leukemia (Couturier et al., 2015; Touzart et al., 2019), where a significant up-regulated relationship with the low-risk group is observed. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.